Ilja Spellmann - Concepedia

Author

Ilja Spellmann

Ludwig-Maximilians-Universität München ORCID

Also Known As

I SPELLMANN, I Spellmann, I. Spellmann, Ilja Spellmann

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

Ludwig-Maximilians-Universität München Isar-Amper-Klinikum München-Ost Heinrich Heine University Düsseldorf Charité - Universitätsmedizin Berlin University of Bonn

About

Ilja Spellmann is an author at Ludwig-Maximilians-Universität München specializing in medicine, psychiatry, and schizophrenia.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	26	2K
2	Social Sciences	12	16	613
3	Immunology	3	3	278
4	Nursing	1	1	10
5	Hospital Medicine	1	1	10

Ilja Spellmann

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine Norbert Müller, Markus Schwarz, Sandra Dehning, Molecular Psychiatry PsychiatryAdd-on Pilot StudyPsychotropic MedicationSubcortical Ischemic DepressionPharmacology	2006	789
Risperidone plasma levels, clinical response and side–effects Michael Riedel, Markus Schwarz, Martin Strassnig, European Archives of Psychiatry and Clinical Neuroscience MedicinePsychotropic MedicationClinical TrialsRisperidone Plasma LevelsPharmacotherapy	2004	138
Elevated macrophage migration inhibitory factor and decreased transforming growth factor-beta levels in major depression — No influence of celecoxib treatment Richard Musil, Markus Schwarz, Michael Riedel, Journal of Affective Disorders InflammationCelecoxib TreatmentPsychiatryGrowth Factor-beta LevelsSubcortical Ischemic Depression	2011	125
IL-2 and IL-4 polymorphisms as candidate genes in schizophrenia Markus Schwarz, Holger Krönig, Michael Riedel, European Archives of Psychiatry and Clinical Neuroscience PsychiatryPsychiatric GeneticsImmunologyGenetic EpidemiologyIl-4 Polymorphisms	2005	81
Quetiapine in the treatment of schizophrenia and related disorders Michael Riedel, Norbert Müller, Martin Strassnig, Neuropsychiatric Disease and Treatment Psychotropic MedicationOfficial Us FoodPsychopharmacologyPharmacotherapySubstantial Selectivity	2007	77
Effects of treatment with the atypical neuroleptic quetiapine on working memory function: a functional MRI follow-up investigation Eva Meisenzahl, Johanna Scheuerecker, Matthew M. Zipse, European Archives of Psychiatry and Clinical Neuroscience Memory FunctionNeurological FunctioningBrain FunctionPsychiatryMemory	2006	74
Decreased T cellular immune response in schizophrenic patients M. Riedel, Ilja Spellmann, Markus Schwarz, Journal of Psychiatric Research Schizophrenic PatientsPsychoneuroimmunologyAutoimmune DiseasePsychiatryMedicine	2006	72
Homer-1 polymorphisms are associated with psychopathology and response to treatment in schizophrenic patients Ilja Spellmann, Dan Rujescu, Richard Musil, Journal of Psychiatric Research Schizophrenic PatientsPsychiatryPsychotic DisorderHomer-1 PolymorphismsPsychiatric Genetics	2010	61
Quetiapine has equivalent efficacy and superior tolerability to risperidone in the treatment of schizophrenia with predominantly negative symptoms Michael Riedel, Norbert Müller, Martin Strassnig, European Archives of Psychiatry and Clinical Neuroscience PsychiatryPsychotic DisorderPsychotropic MedicationPharmacologyPsychopharmacology	2005	59
Effects of risperidone and quetiapine on cognition in patients with schizophrenia and predominantly negative symptoms Michael Riedel, Ilja Spellmann, Martin Strassnig, European Archives of Psychiatry and Clinical Neuroscience PsychopathologyPsychiatryPsychotic DisorderPsychotropic MedicationPsychopharmacology	2007	53

Page 1